 Tinalyn Kupfer
Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histocompatibility Testing | 1 | 2005 | 126 | 0.240 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2005 | 64 | 0.230 |
Why?
| | Autoantigens | 1 | 2005 | 430 | 0.190 |
Why?
| | Antibodies, Monoclonal | 3 | 2018 | 1430 | 0.160 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2018 | 30 | 0.150 |
Why?
| | Transplantation Tolerance | 1 | 2018 | 36 | 0.150 |
Why?
| | Immune Tolerance | 1 | 2018 | 363 | 0.120 |
Why?
| | Graft Survival | 1 | 2018 | 535 | 0.120 |
Why?
| | CD3 Complex | 1 | 2015 | 106 | 0.120 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2015 | 3715 | 0.120 |
Why?
| | Interleukin-1beta | 1 | 2015 | 372 | 0.110 |
Why?
| | Insulin | 2 | 2015 | 2409 | 0.100 |
Why?
| | Antigens, CD20 | 1 | 2013 | 29 | 0.100 |
Why?
| | Mice, Inbred NOD | 3 | 2015 | 601 | 0.100 |
Why?
| | Vaccines, DNA | 1 | 2013 | 32 | 0.100 |
Why?
| | Proinsulin | 1 | 2013 | 54 | 0.100 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 900 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2015 | 460 | 0.090 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 377 | 0.090 |
Why?
| | Spleen | 2 | 2013 | 514 | 0.070 |
Why?
| | B-Lymphocytes | 1 | 2013 | 847 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2018 | 2167 | 0.070 |
Why?
| | Transplantation, Isogeneic | 1 | 2005 | 17 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5757 | 0.060 |
Why?
| | Mice, SCID | 1 | 2005 | 367 | 0.060 |
Why?
| | Antigen Presentation | 1 | 2005 | 218 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2013 | 1091 | 0.050 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2005 | 367 | 0.050 |
Why?
| | Recurrence | 1 | 2005 | 1060 | 0.050 |
Why?
| | Drug Therapy, Combination | 2 | 2015 | 1066 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2005 | 718 | 0.040 |
Why?
| | CD28 Antigens | 1 | 2018 | 53 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2005 | 3015 | 0.040 |
Why?
| | Mice, Inbred C3H | 1 | 2018 | 269 | 0.040 |
Why?
| | Cyclosporine | 1 | 2018 | 268 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2018 | 416 | 0.030 |
Why?
| | Sirolimus | 1 | 2018 | 276 | 0.030 |
Why?
| | Animals | 4 | 2018 | 36940 | 0.030 |
Why?
| | Interleukin-1 Receptor Accessory Protein | 1 | 2015 | 7 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 60 | 0.030 |
Why?
| | Receptors, Interleukin-1 Type I | 1 | 2015 | 23 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 59 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1272 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2005 | 4295 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2015 | 310 | 0.030 |
Why?
| | Graft Rejection | 1 | 2018 | 624 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1142 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2015 | 786 | 0.030 |
Why?
| | Mice | 2 | 2013 | 17787 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 665 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2018 | 828 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2013 | 216 | 0.020 |
Why?
| | Female | 4 | 2018 | 73304 | 0.020 |
Why?
| | Immunotherapy | 1 | 2015 | 641 | 0.020 |
Why?
| | Administration, Oral | 1 | 2013 | 816 | 0.020 |
Why?
| | Pancreas | 1 | 2013 | 329 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1710 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2013 | 491 | 0.020 |
Why?
| | Biomedical Research | 1 | 2015 | 692 | 0.020 |
Why?
| | Research Design | 1 | 2015 | 1139 | 0.020 |
Why?
| | Hyperglycemia | 1 | 2013 | 347 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3284 | 0.020 |
Why?
| | Male | 1 | 2005 | 67762 | 0.010 |
Why?
| | United States | 1 | 2015 | 14841 | 0.010 |
Why?
|
|
Kupfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|